Vimal Mehta
Founder at BIOXCEL THERAPEUTICS, INC.
Net worth: 118 922 $ as of 29/04/2024
Profile
Vimal D.
Mehta is the founder and currently serves as the Chairman & Chief Executive Officer of BioXcel Corp., a company founded in 2005.
He is also the founder and currently holds the position of President, Chief Executive Officer & Director at BioXcel Therapeutics, Inc., which was founded in 2017.
In addition to his founding positions, Dr. Mehta has held former positions at various companies.
He worked as a Director at Invea Therapeutics, Inc. He served as the Manager-Business Development at CuraGen Corp.
from 1996 to 2002.
From 2002 to 2006, he held the role of Senior Vice President-Business Development at Galapagos Biotech Ltd.
Prior to that, he worked as an Assistant Professor at The University of Texas Southwestern Medical Center from 1989 to 1996.
He also served as the Senior Vice President-Business Development at Jubilant Life Sciences (USA), Inc. from 2006 to 2007.
Dr. Mehta obtained his doctorate degree from the University of Delhi.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/04/2024 | 45,564 ( 0.12% ) | 118 922 $ | 29/04/2024 |
Vimal Mehta active positions
| Companies | Position | Start |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Founder | 28/03/2017 |
BioXcel Corp.
 BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | Chief Executive Officer | 31/12/2004 |
Former positions of Vimal Mehta
| Companies | Position | End |
|---|---|---|
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Director/Board Member | 31/12/2022 |
Jubilant Life Sciences (USA), Inc.
 Jubilant Life Sciences (USA), Inc. Medical DistributorsDistribution Services Part of Jubilant Pharmova Ltd., Jubilant Life Sciences (USA), Inc. is a company that wholesales pharmaceuticals. The company is based in Bedminster, NJ. | Corporate Officer/Principal | 31/12/2006 |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 31/12/2005 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | 31/12/2001 |
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | 31/12/1995 |
Training of Vimal Mehta
| University of Delhi | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | Technology Services |
Jubilant Life Sciences (USA), Inc.
Jubilant Life Sciences (USA), Inc. Medical DistributorsDistribution Services Part of Jubilant Pharmova Ltd., Jubilant Life Sciences (USA), Inc. is a company that wholesales pharmaceuticals. The company is based in Bedminster, NJ. | Distribution Services |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Health Technology |
- Stock Market
- Insiders
- Vimal Mehta
